Cite
HARVARD Citation
Pennington, T. et al. (2022). Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma. Australasian journal of dermatology. pp. e133-e137. [Online].